MARKET WIRE NEWS

nDatalyze Corp. Completes Multi-Team Data Collection and Calibration for Epitome Sports Analytics Platform

Source: TheNewsWire

(TheNewswire)

Calgary, AB – TheNewswire - December 15, 2025 – nDatalyze Corp. (CSE:NDAT) (the “Company”) today announced the completion of a keydevelopment milestone for Epitome, its proprietary AI-driven sportsperformance analytics platform, with data collection, testing, andcalibration finalized across three organized hockey teams. Thecompleted dataset includes athletes from two Western Hockey League(WHL) teams and one Ontario University Athletics (OUA) program,providing a multi-level development sample. Management reports thatthe dataset has been used to test, calibrate, and normalizeEpitome’s analytical scoring frameworks across different competitiveenvironments and development stages

“Completing multi-team data collectionand calibration represents an important validation step for theEpitome platform,” said JimDurward, President of nDatalyze Corp . “This milestone materially reducestechnical risk and allows the Company to transition from platformdevelopment toward structured market analysis and commercializationplanning. In elite sports, where incorrect development or acquisitiondecisions can result in substantial financial and competitive losses,validated analytics play an increasingly importantrole.”

Platform Overview - Epitome is designed as adecision-support analytics platform, integrating machine learning withgenomics-informed inputs and proprietary emotional and environmentalperformance assessments. The platform generates individualized athleteprofiles (“Signatures”) intended to support highly-personalizedplayer development strategies, workload management, and organizationaldecision-making. Epitome is not intended to predict specific athleticoutcomes, rather it is designed to complement traditional scouting andperformance analytics by providing objective, upstream insights intofactors that influence long-term development and performancerisk.

Milestone Significance - Management believescompletion of multi-team data collection and calibration:

  • Demonstrates consistency of the analytics frameworkacross independent organizations

  • Reduces single-team and single-environmentbias

  • Supports controlled expansion to additional teams anddevelopment pathways

  • Provides a validated foundation for market segmentationand commercialization planning

NextSteps - With data collection and calibrationcomplete, the Company’s next phase will focus on identifying,defining, and quantifying addressable market segments—includingspecialized hockey academies, junior teams, athlete parents, andscouts—as the basis for a data-driven marketing and salesstrategy.

nDatalyze Corp. is a publicly traded applied AI company focused on developinganalytics platforms that integrate biological, emotional, andenvironmental data to support decision-making in high-risk,performance-driven industries, including sports and mentalhealth.

For Further Information, pleasecontact:

Jim Durward, President, CEO/CTO

Email: [email protected]

nDatalyze Website: https://www.ndatalyze.com

Neither the Canadian Securities Exchange nor itsRegulation Services Provider (as that term is defined in the policiesof the Canadian Securities Exchange) accepts responsibility for theadequacy or accuracy of this release. This news release does notconstitute an offer to sell or a solicitation of an offer to sell anyof the securities in the United States. The securities have not beenand will not be registered under the United States Securities Act of1933, as amended (the "U.S. Securities Act") or any statesecurities laws and may not be offered or sold within the UnitedStates or to U.S. Persons unless registered under the U.S. SecuritiesAct and applicable state securities laws or an exemption from suchregistration is available. The information in this news releaseincludes certain information and statements about management'sview of future events, expectations, plans and prospects thatconstitute forward looking statements. These statements are based uponassumptions that are subject to significant risks and uncertainties.Because of these risks and uncertainties and as a result of a varietyof factors, the actual results, expectations, achievements orperformance may differ materially from those anticipated and indicatedby these forward-looking statements. Any number of factors could causeactual results to differ materially from these forward-lookingstatements as well as future results. Although the Corporationbelieves that the expectations reflected in forward looking statementsare reasonable, it can give no assurances that the expectations of anyforward-looking statements will prove to be correct. Except asrequired by law, the Corporation disclaims any intention and assumesno obligation to update or revise any forward-looking statements toreflect actual results, whether as a result of new information, futureevents, changes in assumptions, changes in factors affecting suchforward-looking statements or otherwise.

Copyright (c) 2025 TheNewswire - All rights reserved.

nDatalyze Corp

NASDAQ: NDATF

NDATF Trading

0.0% G/L:

$0.02 Last:

5,000 Volume:

$0.02 Open:

mwn-ir Ad 300

NDATF Latest News

November 03, 2025 09:00:00 am
nDatalyze Corp. Updates the RTO Progress

NDATF Stock Data

$609,516
31,822,117
5.42%
N/A
Healthcare Providers & Services
Healthcare
CA
Calgary

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App